Mme Docteur NATHALIE FILIPPI

Bibliographie

• Persistence of power Doppler ultrasonography-detected synovitis over 1 year of follow-up predicts poor prognosis in rheumatoid arthritis in clinical remission: the SONORE prospective longitudinal study

  2024

  ArticleRMD Open

• A randomized prospective open-label controlled trial comparing the performance of a connected monitoring interface versus physical routine monitoring in patients with rheumatoid arthritis

  2021

  ArticleRheumatology

• Long-term corticosteroid use and dietary advice: a qualitative analysis of the difficulties encountered by patient

  2019

  ArticleBMC Health Services Research

• Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis

  2018

  ArticleAnnals of the Rheumatic Diseases

• Heart Involvement in a Woman Treated with Hydroxychloroquine for Systemic Lupus Erythematosus Revealing Fabry Disease

  2016

  ArticleJournal of Rheumatology

Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).

Localisation des cabinets

Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.

Lieux de consultation

• CABINET DU DR NATHALIE FILIPPI

  SCM RHUMATO ASSAS — 16 AVENUE D ASSAS, 34000 Montpellier

  Libéral
  © OpenStreetMap

  📷 Street View ↗🗺️ Maps ↗OSM ↗

• HOPITAL LAPEYRONIE CHU MONTPELLIER

  371 Avenue DU DOYEN GASTON GIRAUD, 34295 Montpellier

  ☎ 0467336733Hospitalier🏥 Centre CHU ↗🏥 Voir cet établissement
  127 m171 m

  © OpenStreetMap · Photos Wikimedia Commons (CC)

  📷 Street View ↗🗺️ Maps ↗OSM ↗

Tarifs & secteur de conventionnement

Prendre rendez-vous & contact

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Top publications · les plus citées

• 1

  Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis

  Annals of the rheumatic diseases · 2018

  📚 49 citations🎯 RCR 2.37Top 22% NIH
• 2

  A randomized prospective open-label controlled trial comparing the performance of a connected monitoring interface versus physical routine monitoring in patients with rheumatoid arthritis

  Rheumatology (Oxford, England) · 2021

  📚 35 citations🎯 RCR 3.70Top 12% NIH🩺 Clinique

  Lire l'abstract Crossref ↓

  Abstract Objectives In RA, telemedicine may allow tight control of disease activity while reducing hospital visits. We developed a smartphone application connected with a physician’s interface to monitor RA patients. We aimed to assess the performance of this e-Health solution in comparison with routine practice in the management of patients with RA. Methods A six-month pragmatic, randomized, controlled, prospective, clinical trial was conducted in RA patients with high to moderate disease activity starting a new DMARD therapy. Two groups were established: ‘connected monitoring’ and ‘conventional monitoring’. The primary outcome was the number of physical visits between baseline and six months. Secondary outcomes included adherence, satisfaction, changes in clinical, functional and health status scores (Short-Form 12). Results Of the 94 randomized patients, 89 completed study: 44 in the ‘conventional monitoring’ arm and 45 in the ‘connected monitoring’ arm. The total number of physical visits between required baseline and six-month visits was significantly lower in the ‘connected monitoring’ group [0.42 (0.58) vs 1.93 (0.55); P <0.05]. No differences between groups were observed in the clinical and functional scores. A better quality of life for Short-Form 12 subscores (Role-Physical and Role-Emotional) were found in the ‘connected monitoring’ group. Conclusion Our results suggest that connected monitoring reduces the number of physical visits while maintaining a tight control of disease activity and improving quality of life in patients with RA starting a new treatment. Trial registration ClinicalTrials.gov, https://clinicaltrials.gov, NCT03005925.

• 3

  Long-term corticosteroid use and dietary advice: a qualitative analysis of the difficulties encountered by patient

  BMC health services research · 2019

  📚 15 citations🔓 Open Access📄 PDF gratuit ↗

Publications scientifiques (6) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Datasets & protocoles partagés

• Long-term corticosteroid use and dietary advice: a qualitative analysis of the difficulties encountered by patient

  Collection2019Figshare

  Abstract Background Nearly 1% of the population is currently treated with long-term corticosteroid therapy. When corticosteroids are introduced, information concerning potential adverse effects and recommendations for li

• Long-term corticosteroid use and dietary advice: a qualitative analysis of the difficulties encountered by patient

  Collection2019Figshare

  Abstract Background Nearly 1% of the population is currently treated with long-term corticosteroid therapy. When corticosteroids are introduced, information concerning potential adverse effects and recommendations for li

Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).

Partager cette fiche